as soon as is submitted to ZB.
Stem cell-derived islet therapy: Is this the end of the beginning?
Nat. Rev. Endocrinol. 19, 681-682 (2023)
The debut of stem cell-derived islets in the clinic for glycaemic control in patients with type 1 diabetes mellitus has garnered much excitement. Ongoing research in this field guarantees to be transformative for modern treatment of diabetes mellitus.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Letter to the Editor
ISSN (print) / ISBN
1759-5029
e-ISSN
1759-5037
Journal
Nature Reviews - Endocrinology
Quellenangaben
Volume: 19,
Issue: 12,
Pages: 681-682
Publisher
Nature Publishing Group
Publishing Place
New York, NY
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institut f. Diabetes u. Organoidtech (IDOT)